RenovaLase®
Vaginal Atrophy Laser Treatment
W550ZoN8Dxk
RenovaLase® is a unique and innovative, non-invasive 2940 nm Er:YAG laser therapy for the symptoms of vaginal atrophy. It is based on non-ablative photothermal treatment of the vaginal canal. Clinical studies show that it is an efficient, easy-to-use, quick and safe procedure that eliminates the need for long-term estrogen administration.
How does RenovaLase® work?
The RenovaLase treatment is based on laser-induced, mild and controlled heating of the vaginal tissue, which stimulates angiogenesis, fibroblast activity and new collagen formation without thermal or ablative damage. The final result is increased epithelial thickness as well as vascularization of the lamina propria, along with a reduction of symptoms such as dryness, itching, irritation and dyspareunia.
Promising clinical Results
Scientific results presented by Dr. Marco Gambacciani and Dr. Adrian Gaspar (see Library tab) clearly show a noticeable improvement in the symptoms of vaginal atrophy. Results show favorable changes in the tropism of the vaginal mucosa, with increases in collagen and vascularization as well as in the glycogen level and the epithelial thickness. The positive effects were long lasting as results were sustained at follow-up 6 months after the treatment.
With no need for long-term estrogen treatment, RenovaLase® is also appropriate for patients with estrogen-dependent cancer (such as endometrial cancer, breast cancer, etc.) or with a family background of such cancers, as shown in clinical studies by Dr. Juan F. Bojanini and Dr. Marco Gambacciani (see Scientific & Clinical Research).
Abstracts of published scientific studies examining the effectiveness and safety of Fotona SMOOTH® laser therapy in gynecology can be found in the following Compendium of Clinical Studies.
For more information please visit the Fotona SMOOTH® website which is tailored for both patients and doctors.
Getting started with RenovaLase®
Training in RenovaLase® is provided through the Laser and Health Academy* under the guidance of experts in medical laser technology. The extensive workshop, where participants engage in live demonstrations and gain an in-depth understanding of laser physics and laser-tissue interaction, will provide the needed insight into the fundamentals of noninvasive gynecological treatments and other procedures that can be performed with this special Er:YAG laser system.
Clinical Results
Clinical Results
Genitourinary Syndrome of Menopause
Courtesy of: Adrian Gaspar, MD
Laser source: Non-Ablative Er:YAG
What is VSP?
VSP (Variable Square Pulse) technology is a patented solution for generating square laser pulses for more controlled energy absorption. Pulse durations can be adjusted from 50 us up to 1500 us, depending on the practitioner’s needs. VSP pulse technology minimizes unnecessary laser energy absorption into body tissues and helps to ensure ultimate performance and patient comfort during laser treatments.
Scientific & Clinical Research
Scientific & Clinical Research Library:
The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM) - Read Full Text.
Lin, K.-L., Chou, S.-H., Loo, Z.-X., Liu, Y.-Y., Cheng, J.-C. & Long, C.-Y., 2022. Lasers Med Sci. 2022 Jun;37(4):2203-2208. doi: 10.1007/s10103-021-03484-x
A study of the objective benefits and safety of Er-YAG laser in the treatment of genitourinary syndrome of menopause - Read Full Text.
Avul, Z. & Guven, C.M., 2023. Lasers Med Sci. 2023 Jun 4;38(1):131. doi: 10.1007/s10103-023-03798-y
Laser Treatment of Vaginal Atrophy in Post-menopause and Post-gynecological Cancer Patients - Read Full Text.
Juan F. Bojanini B., Alexandra M. Mejía C. Journal of LA&HA, Vol. 2014, No.1; pp.65-71.
Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause - Read Full Text.
Gambacciani M, Levancini M, Cervigni M. Climacteric 2015 Oct;18(5):757-763
Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors - Read Full Text.
Gambacciani M, Levancini M. Menopause. 2017 Mar;24(3):316-319
Treatment of Genitourinary Syndrome of Menopause with Erbium:YAG Laser: A Prospective Study of Efficacy and Safety of the Treatment for Women after Menopause of Natural Origin and Therapy-Induced Menopause in Breast Cancer Survivors - Read Full Text.
Juan F. Bojanini. J LA&HA - J Laser Health Acad 2016; 2016(1):35-40
Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause - Read Full Text.
Gaspar A, Brandi H, Gomez V, Luque D. Lasers Surg Med. 2017 Feb;49(2):160-168. doi: 10.1002/lsm.22569
Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study - Read Full Text.
Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, Vižintin Z. Lasers Surg Med. 2018 Oct;50(8):802-807. doi: 10.1002/lsm.22826
Long-term Effects of vaginal Erbium Laser in the Treatment of Genitourinary Syndrome of Menopause - Read Full Text.
Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Climacteric. 2018;1(2):148-152. doi:10.1080/13697137.2018.1436538.
Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy - Read Full Text.
Gaspar A, Silva J, Calderon A, Di Placido V, Vizintin Z. Climacteric. 2020;23(sup1):S11-S13. doi: 10.1080/13697137.2020.1764525
Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study - Read Full Text.
Gambacciani M, Albertin E, Torelli MG, Bracco GL, Casagrande AC, Martella L, Baiocchi G, Alfieri S, Russo N, Cervigni M; Italian Vaginal Erbium Laser Academy. Climacteric. 2020;23(sup1):S24-S27. doi: 10.1080/13697137.2020.1804544
Effects of non-ablative Er:YAG laser on the skin and the vaginal wall: systematic review of the clinical and experimental literature - Read Full Text.
Hympanova L, Mackova K, El-Domyati M, et al. International Urogynecology Journal. 2020 Dec;31(12):2473-2484. DOI: 10.1007/s00192-020-04452-9
The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM) - Read Full Text.
Lin KL, Chou SH, Loo ZX, Liu YY, Cheng JC, Long CY. Lasers Med Sci. 2022 Jun;37(4):2203-2208. doi: 10.1007/s10103-021-03484-x
Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause - Read Abstract.
Gambacciani M, Levancini M. Minerva Ginecol. 2015 Apr;67(2):97-102.
* Certain applications discussed in this scientific literature may not yet be cleared by the FDA.
Additional Resources: visit the Laser and Health Academy* website for additional information about medical laser treatments that can be performed with Fotona laser systems.
